Type to search

Nosopharm Welcomes New Members To Supervisory Board | Pharmtech Focus
Nosopharm and GNA NOW Announce Positive Results for the Late Preclinical Development of the First-in-class Antibiotic NOSO-502 | Pharmtech Focus
Nosopharm Signs Partnership with INRAE and University of Montpellier to Develop New Anti-infectives | Pharmtech Focus